Mallet Finger Splinting Study

Night Splinting After 6 to 8 Weeks of Continuous Splinting for Mallet Finger

NCT01388751•Massachusetts General Hospital

Summary

Do patients that night splint for 1 month after 6-8 weeks of continuous splinting for a mallet injury have the same extensor lag 4 months after initiating treatment as patients that do not perform night splinting? Secondary Question: Is night splinting a predictor of DASH score or patient satisfaction (on a 5-Point Likert scale)?

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•All adult, English-speaking patients in the practice of Dr. Jesse Jupiter, Dr. Chaitanya Mudgal, or Dr. David Ring electing splint treatment for mallet deformity will be invited to enroll on their follow-up visit 6-8 weeks after initiating splint treatment.

Exclusion Criteria

•1. Open lesions
•2. Mallet fracture more than 2 weeks old
•3. Mallet fracture with subluxation of the distal interphalangeal joint.

Locations (1)

Massachusetts General Hospital

Boston, Massachusetts, United States

Key Dates

Start Date

November 1, 2008

Primary Completion Date

May 1, 2012

Completion Date

September 1, 2012

Last Updated

October 31, 2012

Enrollment

ACTUAL participants

Conditions

Mallet Finger

Interventions

night splinting

PROCEDURE

Comparative Study Between Micro Plate Fixation and Blocking k.Wire in Management of Acute Bony Mallet Finger : Randomized Controlled Clinical Trial Study

NCT06398483

Acute Bony Mallet Finger

View study

COMPLETEDNA

Conservative Treatment of Mallet Finger Injury

NCT04830917

Conservatively Treated Mallet Finger Injury

View study

UNKNOWNNA

Comparison of Splinting Interventions for Treating Mallet Finger Injuries

NCT00310570

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 31, 2012Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions